On July 21, 2026, Astral Eminent Limited sold 1.09 million shares of BIOCYTOGEN-B (H shares) at an average of HKD 54.4237 per share, involving about HKD 59.46 million.
Prior to the disposal, Astral Eminent Limited's long position in BIOCYTOGEN-B was 13.22 million shares, representing 11.94%; following the disposal, the holding changed to 12.13 million shares, with the long position ratio falling to 10.95%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments